ArticleBMC infectious diseases2026
An unusual case of neurobrucellosis with intracranial hypertension and bilateral abducens nerve palsy.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBrucellosis is one of the most common zoonotic diseases in the world and it can affect many systems. Rarely, central nervous system involvement, which is a serious complication, can be observed. CASE PRESENTATION: Here, we report a case of neurobrucellosis presenting with abducens nerve palsy and intracranial hypertension. A 28-year-old woman engaged in livestock farming. She presented to the emergency department with left-sided weakness, nausea, and vomiting. Neurological examination showed 4/5 muscle strength in the left upper extremity without meningeal signs. Neurobrucellosis was confirmed based on positive Brucella immunocapture (1:5120) and cerebrospinal fluid (CSF) agglutination (1:320) tests. Antimicrobial therapy with ceftriaxone, doxycycline, and rifampicin was initiated. On the 11th day, the patient developed sudden diplopia, and fundoscopic examination revealed bilateral papilledema. Lumbar puncture demonstrated elevated CSF pressure (27 cm/H₂O), indicating intracranial hypertension, while ocular findings were consistent with bilateral abducens nerve palsy as complications of neurobrucellosis. Methylprednisolone and acetazolamide were subsequently added to the treatment regimen. Following clinical improvement, the patient was discharged on day 40. At the third month of follow up, as intracranial pressure normalized, methylprednisolone and acetazolamide were discontinued. Ceftriaxone was replaced with trimethoprim-sulfamethoxazole on day 60. The treatment was ceased at 12th month, with the patient remaining asymptomatic and exhibiting normal findings. Two-year follow-up confirmed complete recovery with no recurrence.
conclusionThis case emphasizes that neurobrucellosis should be considered in patients with neurological manifestations, such as cranial nerve palsy and intracranial hypertension, particularly in endemic regions, and illustrates that timely diagnosis and appropiate antimicrobial and adjunctive therapy can result in complete recovery without long-term sequelae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.